Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 4/2020

01-04-2020 | Bariatric Surgery | Original Contributions

Relationship of Body Composition Measures and Metabolic Basal Rate with Gastrointestinal Hormones in Weight Regain 5 Years After Gastric Bypass

Authors: Silvia Pereira, Carlos Saboya, Andrea Ramalho

Published in: Obesity Surgery | Issue 4/2020

Login to get access

Abstract

Background

To assess the relationship of body composition measures and basal metabolic rate (BMR) with gastrointestinal hormones in weight regain 5 years after gastric bypass.

Methods

A total of 42 patients were divided into two groups: with and without weight regain 5 years after gastric bypass. Hormone assessments were performed after a fasting period and at 30, 60, and 120 min after the standard meal intake.

Results

Patients with no weight regain had significantly lower visceral fat (VF), lower fat body mass (FBM), and lower fat percentage (%F) in relation to the other group. In the group without weight regain, at baseline, glucose-dependent insulinotropic polypeptide (GIP) showed a negative correlation with weight and BMI and a positive correlation with BMR, skeletal muscle mass (SMM), and fat-free mass (FFM). After the standard meal, the following results were found: a negative correlation with %F, a positive correlation of glucagon-like peptide-1 (GLP-1) with FFM, and a positive correlation of GLP-2 and PYY with BMR, SMM, and FFM. In the group with weight regain, at baseline, GIP, PYY, and GLP-1 showed a negative correlation with %F. After the standard meal, PYY and GLP-1 showed a negative correlation with VF, FBM, and %F. On the other hand, GLP-2 negatively correlated with VF and FBM.

Conclusion

It is possible to conclude that there is a different relationship of concentrations of PYY, GIP, GLP-1, and GLP-2 with body composition and BMR in patients with and without weight regain in the late gastric bypass postoperative period.
Literature
1.
Karmali S, Brar B, Shi X, et al. Weight recidivism post-bariatric surgery: a systematic review. Obes Surg. 2013;23(11):1922–33.CrossRef
2.
Tran DD, Nwokeabia ID, Purnell S, et al. Revision of Roux-en-Y gastric bypass for weight regain: a systematic review of techniques and outcomes. Obes Surg. 2016;26(7):1627–34.CrossRef
3.
Sheppard CE, Lester EL, Chuck AW, et al. The economic impact of weight regain. Gastroenterol Res Pract. 2013;2013:379564. ReviewCrossRef
4.
Kanerva N, Larsson I, Peltonen M, et al. Changes in total energy intake and macronutrient composition after bariatric surgery predict long-term weight outcome: findings from the Swedish obese subjects (SOS) study. Am J Clin Nutr. 2017;106(1):136–45.CrossRef
5.
Magro DO, Geloneze B, Delfini R, et al. Long-term weight regain after gastric by-pass: a 5-year prospective study. Obes Surg. 2008;18(6):648–51.CrossRef
6.
Hopkins M, Finlayson G, Duarte C, et al. Modelling the associations between fat-free mass, resting metabolic rate and energy intake in the context of total energy balance. Int J Obes. 2016;40(2):312–8.CrossRef
7.
Hopkins M, Blundell JE. Energy balance, body composition, sedentariness and appetite regulation: pathways to obesity. Clin Sci (Lond). 2016;130(18):1615–28.CrossRef
8.
Svane MS, Jørgensen NB, Bojsen-Møller KN, et al. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery. Int J Obes. 2016;40(11):1699–706.CrossRef
9.
Malin SK, Kashyap SR. Effects of various gastrointestinal procedures on β-cell function in obesity and type 2 diabetes. Surg Obes Relat Dis. 2016;12(6):1213–9.CrossRef
10.
Holst JJ, Gribble F, Horowitz M, et al. Roles of the gut in glucose homeostasis. Diabetes Care. 2016;39(6):884–92.CrossRef
11.
Reinhold RB. Critical analysis of long term weight loss following gastric bypass. Surg Gynecol Obstet. 1982;155:385–94.PubMed
12.
Larrad A, Sanchez-Cabezudo C. Indicadores de calidad en cirurgia bariátrica y critérios de êxito a largo plazo. Cir Esp. 2004;75(3):301–4.CrossRef
13.
Christou NV, Look D, Maclean L. Weight gain after short and long-limb gastric bypass in patients followed for longer than 10 years. Ann Surg. 2006;244:734–40.CrossRef
14.
Gumbs AA, Pomp A, Gagner M. Revisional bariatric surgery for inadequate weight loss. Obes Surg. 2007;17(9):1137–45.CrossRef
15.
Deitel M. Overweight and obesity worldwide now estimated to involve 1.7 billion people. Obes Surg. 2003;13:329–30.CrossRef
16.
Lauti M, Lemanu D, Zeng ISL, et al. Definition determines weight regain outcomes after sleeve gastrectomy. Surg Obes Relat Dis. 2017;13(7):1123–9.CrossRef
17.
Le Roux CW, Welbourn R, Werling M, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg. 2007;246(5):780–5.CrossRef
18.
Carrasco F, Papapietro K, Csendes A, et al. Changes in resting energy expenditure and body composition after weight loss following Roux-en-Y gastric bypass. Obes Surg. 2007;17:608–16.CrossRef
19.
Faria SL, Faria OP, Buffington C, et al. Energy expenditure before and after Roux-en-Y gastric bypass. Obes Surg. 2012;22(9):1450–5.CrossRef
20.
Ravussin E, Lillioja S, Anderson TE, et al. Determinants of 24-hour energy expenditure in man. Methods and results using a metabolic chamber. J Clin Invest. 1986;78(6):1568–78.CrossRef
21.
Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004;240:236–42.CrossRef
22.
DePaula AL, Macedo AL, Schraibman V, et al. Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 20–34. Surg Endosc. 2009;23(8):1724–32.CrossRef
23.
Bergmann NC, Lund A, Gasbjerg LS, et al. Separate and combined effects of GIP and GLP-1 infusions on bone metabolism in overweight men without diabetes. J Clin Endocrinol Metab. 2019;104(7):2953–60.CrossRef
24.
Deacon CF, Nauck MA, Meier J, et al. Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide. J Clin Endocrinol Metab. 2000;85(10):3575–81.PubMed
25.
Le Roux CW, Borg C, Wallis K, et al. Gut hypertrophy after gastric by-pass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation. Ann Surg. 2010;252(1):50–6.CrossRef
26.
Vidal J, de Hollanda A, Jiménez A. GLP-1 is not the key mediator of the health benefits of metabolic surgery. Surg Obes Relat Dis. 2016;
27.
Santo MA, Riccioppo D, Pajecki D, et al. Weight regain after gastric bypass: influence of gut hormones. Obes Surg. 2016;26(5):919–25.CrossRef
28.
Cazzo E, Gestic MA, Utrini MP, et al. Correlation between pre and postoperative levels of GLP-1/GLP-2 and weight loss after Roux-en-Y gastric bypass: a prospective study. Arq Bras Cir Dig. 2016;29(4):257–9.CrossRef
29.
Vincent RP, Ashrafian H, Le Roux C. Mechanisms of disease: the role of gastrointestinal hormones in appetite and obesity. Nat Clin Pract Gastroenterol Hepatol. 2008;5(5):268–77.CrossRef
30.
Browning MG, Rabl C, Campos GM. Blunting of adaptive thermogenesis as a potential additional mechanism to promote weight loss after gastric bypass. Surg Obes Relat Dis. 2017;13(4):669–73.CrossRef
31.
Meguid MM, Glade MJ, Middleton FA. Weight regain after Roux-en-Y: a significant complication related to PYY. Nutrition. 2008;24(9):832–42.CrossRef
32.
Le Roux CW, Batterham RL, Aylwin SJ, et al. Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology. 2006;147(1):3–8.CrossRef
33.
Taqi E, Wallace LE, de Heuvel E, et al. The influence of nutrients, biliary-pancreatic secretions, and systemic trophic hormones on intestinal adaptation in a Roux-en-Y bypass model. J Pediatr Surg. 2010;45(5):987–95.CrossRef
34.
Le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg. 2006;243(1):108–14.CrossRef
35.
Jacobsen SH, Olesen SC, Dirksen C, et al. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg. 2012;22(7):1084–96.CrossRef
36.
DeHollanda A, Jiménez A, Corcelles R, et al. Gastrointestinal hormones and weight loss response after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2014;10(5):814–9.CrossRef
37.
Cazzo E, Gestic MA, Utrini MP, et al. GLP-2: a poorly understood mediator enrolled in various bariatric/metabolic surgery-related pathophysiologic mechanisms. Arq Bras Cir Dig. 2016;29(4):272–5.CrossRef
Metadata
Title
Relationship of Body Composition Measures and Metabolic Basal Rate with Gastrointestinal Hormones in Weight Regain 5 Years After Gastric Bypass
Authors
Silvia Pereira
Carlos Saboya
Andrea Ramalho
Publication date
01-04-2020
Publisher
Springer US
Published in
Obesity Surgery / Issue 4/2020
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-019-04342-0

Other articles of this Issue 4/2020

Obesity Surgery 4/2020 Go to the issue

Original Contributions

The Relationship Between BMI, Body Composition, and Fat Mass Distribution in Rou-en-Y Gastric Bypass Patients

Letter to the Editor

Some Caveats when Interpreting Surgical Mouse Models of Vertical Sleeve Gastrectomy

Brief Communication

Scars Matter: The Importance of Incision Decisions in Bariatric Patients

Original Contributions

One Anastomosis Gastric Bypass Performed with a 150-cm Biliopancreatic Limb Delivers Weight Loss Outcomes Similar to Those with a 200-cm Biliopancreatic Limb at 18 -24 Months

Original Contributions

One Anastomosis Gastric Bypass–Mini-Gastric Bypass (OAGB-MGB) Versus Roux-en-Y Gastric Bypass (RYGB)—a Mid-Term Cohort Study with 612 Patients

Original Contributions

Roux-en-Y Gastric Bypass as a Treatment for Barrett’s Esophagus after Sleeve Gastrectomy